The Role of Metabolic Factors in Renal Cancers
Open Access
- 30 September 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (19) , 7246
Abstract
An increasing number of evidence indicates that metabolic factors may play an important role in the development and progression of certain types of cancers, including renal cell carcinoma (RCC). This tumour is the most common kidney cancer which accounts for approximately 3–5% of malignant tumours in adults. Numerous studies indicated that concomitant diseases, including diabetes mellitus (DM) and hypertension, as well as obesity, insulin resistance, and lipid disorders, may also influence the prognosis and cancer-specific overall survival. However, the results of studies concerning the impact of metabolic factors on RCC are controversial. It appears that obesity increases the risk of RCC development; however, it may be a favourable factor in terms of prognosis. Obesity is closely related to insulin resistance and the development of diabetes mellitus type 2 (DM2T) since the adipocytes in visceral tissue secrete substances responsible for insulin resistance, e.g., free fatty acids. Interactions between insulin and insulin-like growth factor (IGF) system appear to be of key importance in the development and progression of RCC; however, the exact role of insulin and IGFs in RCC pathophysiology remains elusive. Studies indicated that diabetes increased the risk of RCC, but it might not alter cancer-related survival. The risk associated with a lipid profile is most mysterious, as numerous studies provided conflicting results. Even though large studies unravelling pathomechanisms involved in cancer growth are required to finally establish the impact of metabolic factors on the development, progression, and prognosis of renal cancers, it seems that the monitoring of health conditions, such as diabetes, low body mass index (BMI), and lipid disorders is of high importance in clear-cell RCC.Keywords
This publication has 106 references indexed in Scilit:
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With SunitinibJNCI: Journal of the National Cancer Institute, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFκB/HIF-1α activationCellular Signalling, 2010
- Epidemiology and risk factors for kidney cancerNature Reviews Urology, 2010
- Inflammation and oncogenesis: a vicious connectionCurrent Opinion in Genetics & Development, 2010
- Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of CancerCancer Epidemiology, Biomarkers & Prevention, 2009
- Reproductive Factors and Risk of Renal Cell Cancer: The Nurses' Health StudyAmerican Journal of Epidemiology, 2009
- Dietary fat and risk of renal cell carcinoma in the USA: a case–control studyBritish Journal of Nutrition, 2008
- Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population‐based study in ChinaInternational Journal of Cancer, 2007
- History of treated hypertension and diabetes mellitus and risk of renal cell cancerAnnals of Oncology, 2006